ES2157996T3 - Nueva composicion. - Google Patents

Nueva composicion.

Info

Publication number
ES2157996T3
ES2157996T3 ES94931943T ES94931943T ES2157996T3 ES 2157996 T3 ES2157996 T3 ES 2157996T3 ES 94931943 T ES94931943 T ES 94931943T ES 94931943 T ES94931943 T ES 94931943T ES 2157996 T3 ES2157996 T3 ES 2157996T3
Authority
ES
Spain
Prior art keywords
new composition
base
eter
surfactant
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94931943T
Other languages
English (en)
Inventor
Harvey Lee Zimmerman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26303736&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2157996(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB939321876A external-priority patent/GB9321876D0/en
Priority claimed from GB939322288A external-priority patent/GB9322288D0/en
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Application granted granted Critical
Publication of ES2157996T3 publication Critical patent/ES2157996T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

UNA COMPOSICION FARMACEUTICA O VETERINARIA QUE CONTIENE UNA BASE DE CREMA CUYA BASE CONTIENE UN ACEITE MINERAL; UNO O MAS ALCOHOLES GRASOS O ESTERES GRASOS; UN SURFACTANTE DE ESTER O DE ETER DE POLIOXIETILENO; Y AGUA.
ES94931943T 1993-10-22 1994-10-20 Nueva composicion. Expired - Lifetime ES2157996T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939321876A GB9321876D0 (en) 1993-10-22 1993-10-22 Novel composition
GB939322288A GB9322288D0 (en) 1993-10-29 1993-10-29 Novel composition

Publications (1)

Publication Number Publication Date
ES2157996T3 true ES2157996T3 (es) 2001-09-01

Family

ID=26303736

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94931943T Expired - Lifetime ES2157996T3 (es) 1993-10-22 1994-10-20 Nueva composicion.

Country Status (28)

Country Link
US (1) US6025389A (es)
EP (1) EP0727979B1 (es)
JP (1) JPH09506865A (es)
KR (1) KR100374462B1 (es)
CN (1) CN1102410C (es)
AP (1) AP608A (es)
AT (1) ATE202467T1 (es)
AU (1) AU692486B2 (es)
BG (1) BG62912B1 (es)
BR (1) BR9407840A (es)
CA (1) CA2174658C (es)
CZ (1) CZ292223B6 (es)
DE (1) DE69427589T2 (es)
DK (1) DK0727979T3 (es)
ES (1) ES2157996T3 (es)
FI (1) FI116931B (es)
GR (1) GR3036591T3 (es)
HK (1) HK1012284A1 (es)
HU (1) HU221853B1 (es)
NO (1) NO313446B1 (es)
NZ (1) NZ275282A (es)
OA (1) OA10361A (es)
PL (1) PL177592B1 (es)
PT (1) PT727979E (es)
RO (1) RO112987B1 (es)
SK (1) SK280222B6 (es)
UA (1) UA39896C2 (es)
WO (1) WO1995010999A1 (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000048812A (ko) * 1996-10-01 2000-07-25 스튜어트 알. 수터, 스티븐 베네티아너, 피터 존 기딩스 병원성 유기체에 의한 비인두 전이증식 관련 세균 감염 치료용약제를 제조하기 위한 뮤피로신의 용도
CO4910145A1 (es) * 1996-10-01 2000-04-24 Smithkline Beecham Corp Uso
CA2303443A1 (en) * 1997-09-11 1999-03-18 Anthony Guy Hatton Compositions adapted for prolonged residence in the nasal pharynx
IL123143A (en) * 1998-02-02 2001-08-26 Agis Ind 1983 Ltd Pharmaceutical compositions containing mupirocin
GB9808470D0 (en) 1998-04-22 1998-06-17 Smithkline Beecham Plc Novel process and apparatus
IL137363A (en) * 2000-07-18 2005-12-18 Agis Ind 1983 Ltd Pharmaceutical compositions containing mupirocin
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
WO2005009336A2 (en) * 2003-05-01 2005-02-03 Replidyne, Inc. Antibacterial methods and compositions
US20050123575A1 (en) * 2003-12-03 2005-06-09 Eilon Asculai Spreadable compositions for topical use, an improved process of making same and methods of using same
WO2008007182A2 (en) * 2006-07-07 2008-01-17 Glenmark Pharmaceuticals Limited Topical pharmaceutical compositions of mupirocin or pharmaceutically acceptable salts or esters thereof
HUE041512T2 (hu) 2010-03-30 2019-05-28 Helperby Therapeutics Ltd Új kombináció és alkalmazás
DK2600869T3 (da) 2010-08-05 2020-11-16 Helperby Therapeutics Ltd Kombination af en pyrroloquinolinforbindelse og et beta-lactam-antimikrobielt middel, mupirocin eller chlorhexidin
GB201013207D0 (en) 2010-08-05 2010-09-22 Helperby Therapeutics Ltd Novel combination
GB201015079D0 (en) 2010-09-10 2010-10-27 Helperby Therapeutics Ltd Novel use
JP2013538868A (ja) 2010-10-08 2013-10-17 ヘルパービー セラピューティクス リミテッド 新規な組成物
ES2702490T3 (es) 2011-05-03 2019-03-01 Dupont Nutrition Biosci Aps Bacterias probióticas para el tratamiento tópico de trastornos de la piel
GB201107755D0 (en) 2011-05-10 2011-06-22 Helperby Therapeutics Ltd Novel compounds
CN102335122B (zh) * 2011-06-21 2013-04-17 北京协和药厂 一种莫匹罗星软膏及其制备方法
DE102012215511A1 (de) 2012-08-31 2014-06-12 Schülke & Mayr GmbH Verfahren zur Herstellung einer Bispyridiniumalkan enthaltenden halbfesten Zubereitung
GB201305277D0 (en) 2013-03-22 2013-05-01 Helperby Therapeutics Ltd Novel combination and use
GB201307989D0 (en) 2013-05-02 2013-06-12 Helperby Therapeutics Ltd Novel combinations and use
EP3082424B1 (en) 2013-12-17 2023-10-04 Hatchtech Pty Ltd Pediculicidal composition
GB201401617D0 (en) 2014-01-30 2014-03-19 Helperby Therapeutics Ltd Novel combination and use
HUE052575T2 (hu) 2014-12-18 2021-05-28 Helperby Therapeutics Ltd Új kombináció és alkalmazás
WO2016133471A1 (en) 2015-02-20 2016-08-25 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A. Ş. A topical composition comprising mupirocin and dexpanthenol
GB201518969D0 (en) 2015-10-27 2015-12-09 Helperby Therapeutics Ltd Triple combination
US10293005B2 (en) 2016-04-19 2019-05-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of gram negative species to treat atopic dermatitis
CN109310626A (zh) 2016-04-19 2019-02-05 美利坚合众国,由健康及人类服务部部长代表 革兰氏阴性种治疗特应性皮炎的用途
GB201610869D0 (en) 2016-06-22 2016-08-03 Helperby Therapeutics Ltd Combination
GB201620095D0 (en) 2016-11-28 2017-01-11 Terali Innov Sas And Univ De Strasbourg And Inserm (Inst Nat De La Sante Et De La Rech Medicale) And Novel use
GB201709193D0 (en) 2017-06-09 2017-07-26 Helperby Therapeutics Ltd Combination
WO2019141957A1 (en) 2018-01-19 2019-07-25 Cado Biotechnology Ivs N-pyrimidinyl hydroxy pyrazole derivatives and uses thereof
SG11202011188SA (en) 2018-05-11 2020-12-30 Forte Subsidiary Inc Compositions for the treatment of skin conditions
WO2020081109A1 (en) * 2018-10-17 2020-04-23 Glenmark Pharmaceuticals Inc., Usa Mupirocin cream in pump device
IL271778A (en) 2019-12-31 2021-06-30 Ichilov Tech Ltd Methods for treating atopic dermatitis
WO2021203136A1 (en) * 2020-03-31 2021-10-07 Chemistryrx Methods for treating hyperpigmentation and compositions for same
EP4313088A1 (en) 2021-03-30 2024-02-07 DuPont Nutrition Biosciences ApS Compositions and methods for treating and preventing gastrointestinal inflammation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3758686A (en) * 1971-12-07 1973-09-11 American Cyanamid Co Method of using steroid acetonides
US3934013A (en) * 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition
NZ200918A (en) * 1981-07-02 1985-07-31 Gist Brocades Nv Stable fatty oil-in-water emulsion cream for topical application
GB8530796D0 (en) * 1985-12-13 1986-01-22 Beecham Group Plc Pharmaceutical composition
IE59628B1 (en) * 1986-06-26 1994-03-09 Beecham Group Plc Treatment of fungal infections
US4847068A (en) * 1987-08-06 1989-07-11 Johnson & Johnson Consumer Products, Inc. Skin care compositions

Also Published As

Publication number Publication date
AU692486B2 (en) 1998-06-11
FI961720A0 (fi) 1996-04-19
AP608A (en) 1997-08-28
JPH09506865A (ja) 1997-07-08
BG100501A (bg) 1996-12-31
US6025389A (en) 2000-02-15
CN1102410C (zh) 2003-03-05
HK1012284A1 (en) 1999-07-30
CZ292223B6 (cs) 2003-08-13
FI116931B (fi) 2006-04-13
FI961720A (fi) 1996-04-19
AU8084794A (en) 1995-05-08
BR9407840A (pt) 1997-05-13
ATE202467T1 (de) 2001-07-15
PL314038A1 (en) 1996-08-05
SK280222B6 (sk) 1999-10-08
AP9600798A0 (en) 1996-04-30
NO961588L (no) 1996-04-19
DE69427589D1 (de) 2001-08-02
HU9601030D0 (en) 1996-06-28
WO1995010999A1 (en) 1995-04-27
NO313446B1 (no) 2002-10-07
NO961588D0 (no) 1996-04-19
CA2174658A1 (en) 1995-04-27
HUT74510A (en) 1997-01-28
CZ112096A3 (en) 1996-07-17
SK49596A3 (en) 1997-02-05
RO112987B1 (ro) 1998-03-30
NZ275282A (en) 1996-10-28
PT727979E (pt) 2001-11-30
EP0727979A4 (en) 1996-11-27
BG62912B1 (bg) 2000-11-30
DE69427589T2 (de) 2002-04-25
DK0727979T3 (da) 2001-10-01
CA2174658C (en) 2000-12-19
EP0727979B1 (en) 2001-06-27
UA39896C2 (uk) 2001-07-16
PL177592B1 (pl) 1999-12-31
KR100374462B1 (ko) 2003-06-09
HU221853B1 (hu) 2003-02-28
EP0727979A1 (en) 1996-08-28
OA10361A (en) 2001-11-21
CN1135715A (zh) 1996-11-13
GR3036591T3 (en) 2001-12-31

Similar Documents

Publication Publication Date Title
ES2157996T3 (es) Nueva composicion.
MX9306499A (es) Composiciones farmaceuticas que contienen una anfetamina.
NO940288L (no) Formuleringer inneholdende umettede fettsyrer
DE69303708D1 (de) Polyhydroxyfettsäureamide enthaltende flüssigkeitszusammensetzungen
HUP9900925A2 (hu) Napfényt szűrő készítmények
FI925533A (fi) Tantal- eller niobbaserad perovskit och foerfarande foer framstaellning daerav
PT88270A (pt) Processo para a preparacao de esteres carboxi/carboxilato que emitam gorduras de baixo valor calorico, sua utilizacao e composicoes que os contem
NO953692D0 (no) Törkeraktiverte stoffkondisjonerende sammensetninger inneholdende umettede fettsyrer
FI941056A (fi) Kalsiumia ja polyhydroksirasvahappoamidia sisältäviä pesuainekoostumuksia
ES2181993T3 (es) Composiciones para el cuidado de la piel que contienen retinol o ester de retinilo.
MX9304972A (es) COMPOSICIONES DETERGENTES LIQUIDAS QUE CONTIENEN PROTEASA Y CIERTOS ACIDOS Y ESTERES ß-AMINOALQUILBORONICOS.
PT942721E (pt) Composicao liquida compreendendo um inibidor de protease de vih e um acido gordo c12-c18
ES2168247T3 (es) Composicion cosmetica que comprende la asociacion de un ester particular y de un compuesto silicona.
ES2058422T3 (es) Adyuvantes para su uso con agentes protectores de cosechas.
PT831826E (pt) Composicao farmaceutica que inclui um inibidor de proteinase e um monoglicerideo
AU6948194A (en) Inhibition of expression of beta-lactamase using esters of fatty acid alcohols
KR950010875A (ko) 피부외용제
EP0596284A3 (de) Antimycotische kosmetische und dermatologische Zubereitungen mit einem Gehalt an Fettsäureestern.
MX9101845A (es) Composiciones antiplaca mejoradas que comprenden una combinacion de alcohol morfolinoamino y agente quelante
DE69302098D1 (de) Zusammensetzungen von hexitan-fettsäureestern
ES2169908T3 (es) Emulsiones pit cosmeticas.
NO953632D0 (no) Anordning for ekstirpasjon av åreknuter
BR9708031A (pt) Oleo hidráulico à base de ésteres de ácidos graxos naturais processo para a sua fabricação e uso de um material contendo éster de talóleo
NZ314603A (en) Triglyceride oil-based oral drench containing an avermectin an oil an antioxidant and a fatty acid ester
DE59404990D1 (de) Fettsäureester von Methylglucosid-Derivaten

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 727979

Country of ref document: ES